Close Menu

Othman Laraki, the CEO and co-founder of Color Genomics, tells Barron's Penta that what his firm is doing differs from that of other genetic testing companies in that it is not following the direct-to-consumer model and offers a clinical product. As Penta notes, Color currently offers a saliva-based test of genetic variants linked to risk of cancers like breast, colon, and pancreatic cancer, as well as to heart disease and medication response.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.